HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Trischitta Selected Research

ectonucleotide pyrophosphatase phosphodiesterase 1

6/2013The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.
8/2001A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities.
9/2000Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Trischitta Research Topics

Disease

18Insulin Resistance
11/2013 - 01/2000
8Type 2 Diabetes Mellitus (MODY)
01/2017 - 09/2000
4Albuminuria
01/2013 - 03/2000
3Obesity
11/2013 - 11/2000
3Glucose Intolerance
11/2013 - 02/2001
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2010 - 09/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2015 - 06/2008
2Body Weight (Weight, Body)
06/2009 - 07/2000
2Bone Resorption
03/2008 - 10/2002
2Diabetic Nephropathies (Diabetic Nephropathy)
09/2004 - 09/2002
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2002 - 03/2000
1Dyslipidemias (Dyslipidemia)
04/2017
1Hyperuricemia
12/2015
1Stroke (Strokes)
12/2015
1Cardiovascular Diseases (Cardiovascular Disease)
12/2015
1Myocardial Infarction
12/2015
1Renal Insufficiency (Renal Failure)
12/2015
1Weight Loss (Weight Reduction)
06/2013
1Inflammation (Inflammations)
01/2013
1Mason-Type Diabetes
01/2013
1Cushing Syndrome
03/2008
1Osteoporotic Fractures
03/2008
1Osteoporosis
03/2008
1Endocrine System Diseases (Endocrine Diseases)
10/2002
1Sclerosis
09/2002
1Diabetes Mellitus
02/2001
1Acromegaly
02/2001
1Hypertension (High Blood Pressure)
02/2001
1Pheochromocytoma
01/2001
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2001
1Thyroid Nodule (Nodule, Thyroid)
11/2000
1Morbid Obesity
11/2000
1Hypothyroidism
11/2000
1Insulinoma
01/2000
1Hyperinsulinism (Hyperinsulinemia)
01/2000
1Hepatocellular Carcinoma (Hepatoma)
01/2000

Drug/Important Bio-Agent (IBA)

9Glucose (Dextrose)FDA LinkGeneric
11/2013 - 01/2000
7Insulin (Novolin)FDA Link
01/2013 - 01/2000
6Insulin ReceptorIBA
11/2013 - 01/2000
4Proteins (Proteins, Gene)FDA Link
01/2013 - 01/2000
3ectonucleotide pyrophosphatase phosphodiesterase 1IBA
06/2013 - 09/2000
2LipidsIBA
04/2017 - 06/2013
2Genetic Markers (Genetic Marker)IBA
01/2017 - 12/2015
2AdiponectinIBA
04/2011 - 03/2010
2HDL CholesterolIBA
03/2010 - 08/2001
23' Untranslated Regions (3' UTR)IBA
02/2010 - 09/2005
2Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
09/2005 - 09/2004
2PPAR gammaIBA
03/2005 - 11/2003
2CreatinineIBA
09/2002 - 03/2000
1urate transporterIBA
12/2015
1Uric Acid (Urate)IBA
12/2015
1AlbuminsIBA
01/2013
1GlucokinaseIBA
01/2013
1AdipokinesIBA
01/2013
1Protein Isoforms (Isoforms)IBA
03/2010
1Testosterone (Sustanon)FDA Link
06/2009
1Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA
06/2008
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2008
1GonadotropinsIBA
03/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2008
1Hormones (Hormone)IBA
03/2008
1CalciumIBA
03/2008
1GlucocorticoidsIBA
03/2008
1CytokinesIBA
03/2008
1Glucosamine (Dona)IBA
09/2003
1OsteocalcinIBA
10/2002
1Technetium Tc 99m MedronateIBA
10/2002
1Biomarkers (Surrogate Marker)IBA
10/2002
1DecorinIBA
09/2002
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2002
1Antihypertensive Agents (Antihypertensives)IBA
09/2002
1CholesterolIBA
08/2001
1Messenger RNA (mRNA)IBA
08/2001
1Glutamine (L-Glutamine)FDA Link
04/2001
1Lysine (L-Lysine)FDA Link
04/2001
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
04/2001
1Codon (Codons)IBA
01/2001
1Cysteine (L-Cysteine)FDA Link
01/2001
1ImmunosorbentsIBA
11/2000
1Ethanol (Ethyl Alcohol)IBA
11/2000
1Thyroxine (Levothyroxine)FDA LinkGeneric
11/2000
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
11/2000
1EnzymesIBA
11/2000
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2000
1Tolbutamide (Orinase)FDA LinkGeneric
09/2000
1Growth Hormone (Somatotropin)IBA
07/2000
1Glycoproteins (Glycoprotein)IBA
03/2000
1Amino AcidsFDA Link
03/2000
1GlycogenIBA
01/2000
1Phosphotransferases (Kinase)IBA
01/2000

Therapy/Procedure

1Glycemic Control
11/2012
1Therapeutics
09/2002
1Intravenous Injections
09/2000